September 19th, 2024
GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy
GC Therapeutics (GCTx), a Harvard startup, announced its launch to scale and its technology TFome™, the world’s first “plug and play” induced pluripotent stem cell (iPSC) programming platform for cell therapies in multiple therapeutic areas.